A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis.
Saved in:
| Title: | A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis. |
|---|---|
| Authors: | Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Migliaccio AR; Altius Institute for Biomedical Sciences, Seattle, Washington., Kosiorek H; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona., Bhave R; Comprehensive Cancer Center of Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina., Palmer J; Mayo Clinic Scottsdale, Arizona., Kuykendall A; Department of Hematologic Malignancy, Moffitt Cancer Center, Tampa, Florida., Mesa R; Comprehensive Cancer Center of Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina., Rampal RK; Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York., Gerds AT; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Yacoub A; The University of Kansas Cancer Center, Westwood, Kansas., Pettit K; University of Michigan, Comprehensive Cancer Center, Ann Arbor, Michigan., Talpaz M; University of Michigan, Comprehensive Cancer Center, Ann Arbor, Michigan., Komrokji R; Department of Hematologic Malignancy, Moffitt Cancer Center, Tampa, Florida., Kremyanskaya M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Gonzalez A; The University of Texas Health Science Center at San Antonio, San Antonio, Texas., Fabris F; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Johnson K; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Dougherty M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., McGovern E; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Arango Ossa J; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Domenico D; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Farnoud N; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York., Weinberg RS; New York Blood Center, New York, New York., Kong A; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Najfeld V; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York., Vannucchi AM; University of Florence, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Arciprete F; Unit of Microscopic and Ultrastructural Anatomy, University Campus Bio-Medico, Rome, Italy., Zingariello M; Unit of Microscopic and Ultrastructural Anatomy, University Campus Bio-Medico, Rome, Italy., Falchi M; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Viale Regina Elena Rome Italy., Salama ME; Sonic Healthcare, Austin, Texas., Mead-Harvey C; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona., Dueck A; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona., Varricchio L; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Hoffman R; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Sep 15; Vol. 29 (18), pp. 3622-3632. |
| Publication Type: | Clinical Trial, Phase I; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37439808 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mascarenhas+J%22">Mascarenhas J</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Migliaccio+AR%22">Migliaccio AR</searchLink>; Altius Institute for Biomedical Sciences, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Kosiorek+H%22">Kosiorek H</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona.<br /><searchLink fieldCode="AU" term="%22Bhave+R%22">Bhave R</searchLink>; Comprehensive Cancer Center of Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina.<br /><searchLink fieldCode="AU" term="%22Palmer+J%22">Palmer J</searchLink>; Mayo Clinic Scottsdale, Arizona.<br /><searchLink fieldCode="AU" term="%22Kuykendall+A%22">Kuykendall A</searchLink>; Department of Hematologic Malignancy, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Mesa+R%22">Mesa R</searchLink>; Comprehensive Cancer Center of Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina.<br /><searchLink fieldCode="AU" term="%22Rampal+RK%22">Rampal RK</searchLink>; Leukemia Service, Department of Medicine, Center for Hematologic Malignancies, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Gerds+AT%22">Gerds AT</searchLink>; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Yacoub+A%22">Yacoub A</searchLink>; The University of Kansas Cancer Center, Westwood, Kansas.<br /><searchLink fieldCode="AU" term="%22Pettit+K%22">Pettit K</searchLink>; University of Michigan, Comprehensive Cancer Center, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Talpaz+M%22">Talpaz M</searchLink>; University of Michigan, Comprehensive Cancer Center, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Komrokji+R%22">Komrokji R</searchLink>; Department of Hematologic Malignancy, Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Kremyanskaya+M%22">Kremyanskaya M</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Gonzalez+A%22">Gonzalez A</searchLink>; The University of Texas Health Science Center at San Antonio, San Antonio, Texas.<br /><searchLink fieldCode="AU" term="%22Fabris+F%22">Fabris F</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Johnson+K%22">Johnson K</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Dougherty+M%22">Dougherty M</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22McGovern+E%22">McGovern E</searchLink>; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Arango+Ossa+J%22">Arango Ossa J</searchLink>; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Domenico+D%22">Domenico D</searchLink>; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Farnoud+N%22">Farnoud N</searchLink>; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Weinberg+RS%22">Weinberg RS</searchLink>; New York Blood Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Kong+A%22">Kong A</searchLink>; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Najfeld+V%22">Najfeld V</searchLink>; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Vannucchi+AM%22">Vannucchi AM</searchLink>; University of Florence, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Arciprete+F%22">Arciprete F</searchLink>; Unit of Microscopic and Ultrastructural Anatomy, University Campus Bio-Medico, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Zingariello+M%22">Zingariello M</searchLink>; Unit of Microscopic and Ultrastructural Anatomy, University Campus Bio-Medico, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Falchi+M%22">Falchi M</searchLink>; National HIV/AIDS Research Center, Istituto Superiore di Sanità, Viale Regina Elena Rome Italy.<br /><searchLink fieldCode="AU" term="%22Salama+ME%22">Salama ME</searchLink>; Sonic Healthcare, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Mead-Harvey+C%22">Mead-Harvey C</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona.<br /><searchLink fieldCode="AU" term="%22Dueck+A%22">Dueck A</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona.<br /><searchLink fieldCode="AU" term="%22Varricchio+L%22">Varricchio L</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Hoffman+R%22">Hoffman R</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2023 Sep 15; Vol. 29 (18), pp. 3622-3632. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37439808 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1078-0432.CCR-23-0276 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3622 Titles: – TitleFull: A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mascarenhas J – PersonEntity: Name: NameFull: Migliaccio AR – PersonEntity: Name: NameFull: Kosiorek H – PersonEntity: Name: NameFull: Bhave R – PersonEntity: Name: NameFull: Palmer J – PersonEntity: Name: NameFull: Kuykendall A – PersonEntity: Name: NameFull: Mesa R – PersonEntity: Name: NameFull: Rampal RK – PersonEntity: Name: NameFull: Gerds AT – PersonEntity: Name: NameFull: Yacoub A – PersonEntity: Name: NameFull: Pettit K – PersonEntity: Name: NameFull: Talpaz M – PersonEntity: Name: NameFull: Komrokji R – PersonEntity: Name: NameFull: Kremyanskaya M – PersonEntity: Name: NameFull: Gonzalez A – PersonEntity: Name: NameFull: Fabris F – PersonEntity: Name: NameFull: Johnson K – PersonEntity: Name: NameFull: Dougherty M – PersonEntity: Name: NameFull: McGovern E – PersonEntity: Name: NameFull: Arango Ossa J – PersonEntity: Name: NameFull: Domenico D – PersonEntity: Name: NameFull: Farnoud N – PersonEntity: Name: NameFull: Weinberg RS – PersonEntity: Name: NameFull: Kong A – PersonEntity: Name: NameFull: Najfeld V – PersonEntity: Name: NameFull: Vannucchi AM – PersonEntity: Name: NameFull: Arciprete F – PersonEntity: Name: NameFull: Zingariello M – PersonEntity: Name: NameFull: Falchi M – PersonEntity: Name: NameFull: Salama ME – PersonEntity: Name: NameFull: Mead-Harvey C – PersonEntity: Name: NameFull: Dueck A – PersonEntity: Name: NameFull: Varricchio L – PersonEntity: Name: NameFull: Hoffman R IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 09 Text: 2023 Sep 15 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1557-3265 Numbering: – Type: volume Value: 29 – Type: issue Value: 18 Titles: – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research Type: main |
| ResultId | 1 |